Your browser doesn't support javascript.
loading
Utility of 18F-fluoroestradiol (18F-FES) PET/CT imaging as a pharmacodynamic marker in patients with refractory estrogen receptor-positive solid tumors receiving Z-endoxifen therapy.
Lin, Frank I; Gonzalez, E M; Kummar, S; Do, K; Shih, J; Adler, S; Kurdziel, K A; Ton, A; Turkbey, B; Jacobs, P M; Bhattacharyya, S; Chen, A P; Collins, J M; Doroshow, J H; Choyke, P L; Lindenberg, M L.
Afiliación
  • Lin FI; Cancer Imaging Program, National Cancer Institute, NIH, Bethesda, MD, USA. frank.lin2@nih.gov.
  • Gonzalez EM; Molecular Imaging Program, National Cancer Institute, Bethesda, MD, USA. frank.lin2@nih.gov.
  • Kummar S; Molecular Imaging Program, National Cancer Institute, Bethesda, MD, USA.
  • Do K; Division of Cancer Treatment and Diagnosis and Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Shih J; Division of Cancer Treatment and Diagnosis and Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Adler S; Biometric Research Program, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Kurdziel KA; Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc., NCI Campus at Frederick, Frederick, MD, 21702, USA.
  • Ton A; Molecular Imaging Program, National Cancer Institute, Bethesda, MD, USA.
  • Turkbey B; Molecular Imaging Program, National Cancer Institute, Bethesda, MD, USA.
  • Jacobs PM; Molecular Imaging Program, National Cancer Institute, Bethesda, MD, USA.
  • Bhattacharyya S; Cancer Imaging Program, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Chen AP; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Frederick, MD, USA.
  • Collins JM; Early Clinical Trials Development Program, DCTD, National Cancer Institute, Bethesda, MD, USA.
  • Doroshow JH; Division of Cancer Treatment and Diagnosis and Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Choyke PL; Division of Cancer Treatment and Diagnosis and Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Lindenberg ML; Molecular Imaging Program, National Cancer Institute, Bethesda, MD, USA.
Eur J Nucl Med Mol Imaging ; 44(3): 500-508, 2017 Mar.
Article en En | MEDLINE | ID: mdl-27872957
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neoplasias de la Mama Masculina / Radiofármacos / Estradiol / Tomografía Computarizada por Tomografía de Emisión de Positrones / Neoplasias de los Genitales Femeninos Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neoplasias de la Mama Masculina / Radiofármacos / Estradiol / Tomografía Computarizada por Tomografía de Emisión de Positrones / Neoplasias de los Genitales Femeninos Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos